BD Veo™ insulin syringes with BD Ultra-Fine™ 6mm x 31G needle

Give your patient less to fear with less needle, less pain, and less chance of intramuscular injection.*1,2

BD Veo™insulin syringes feature the shortest BD Ultra-Fine™ needle, 53% shorter than the 12.7-mm needle. This length is supported by recent recommendations published in Mayo Clinic Proceedings that advocate using the shortest needle first-line for all patient categories.1† Preferred by most patients over their current needle length, BD Veo insulin syringes provide approximately 8x-lower risk of intramuscular injection compared to a 12.7-mm needle.2,3‡

Four barrel sizes

BD Veo insulin syringes come in four different barrel sizes and scale capacities to optimize dose.

Reduced risk of hypoglycemia

Longer needle lengths may lead to frequent IM vs subcutaneous tissue injections, which may cause unexplained hypoglycemia.1,2

BD Veo insulin syringe with BD Ultra-Fine 6mm needle
Catalog no.BD NDC/HRI no.Syringe sizee-catalog
324912 08290-3249-12 1 mL 6 mm (15/64 in) x 31 G
324911 08290-3249-11 1/2 mL 6 mm (15/64 in) x 31 G
324909 08290-3249-09 3/10 mL 6mm (15/64 in) x 31 G
BD Veo insulin syringe with BD Ultra-Fine 6mm needle with half-unit scale
Catalog no.BD NDC/HRI no.Syringe sizee-catalog
324910 08290-3249-10 3/10 mL 6 mm (15/64 in) x 31 G

Testimonial Videos

How to Inject With Insulin Syringes Videos

Related Videos



Notes

* When compared to longer and thicker insulin syringe needles

† Excluding safety syringes

‡ Calculations assume a needle inserted at 90° without a pinch-up technique in an adult population

References
  1. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
  2. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
  3. BD 6mm Insulin Syringe Voice of Customer Market Research Report, August 2017.